Newfound Research’s Bristol-Myers Squibb BMY Stock Holding History

Newfound Research’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-555	Closed	-$43K	–	132
2022 Q2	$43K	Buy	+555	New	+$42.3K	0.09%	129
2021 Q1	–	Sell	-1,281	Closed	-$79K	–	131
2020 Q4	$79K	Buy	+1,281	New	+$78.8K	0.2%	93
2020 Q2	–	Sell	-1	Closed	–	–	66
2020 Q1	$0	Hold	1	–	–	﹤0.01%	102
2019 Q4	$0	Hold	1	–	–	﹤0.01%	151
2019 Q3	$0	Buy	+1	New	+$47	﹤0.01%	163

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newfound Research's BMY Position: Q3 2022 in Review

Newfound Research sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 555 shares — an estimated $43K sold.

Newfound Research first reported a position in BMY in Q3 2019 and held it in 5 quarters. The position peaked at $79K in Q4 2020. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Newfound Research reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Newfound Research sold 555 Bristol-Myers Squibb shares in Q3 2022, an estimated $43K.
Newfound Research first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 5 quarters.
Newfound Research's Bristol-Myers Squibb position peaked at $79K in Q4 2020.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.